全文获取类型
收费全文 | 1436篇 |
免费 | 94篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 18篇 |
妇产科学 | 5篇 |
基础医学 | 292篇 |
口腔科学 | 32篇 |
临床医学 | 91篇 |
内科学 | 429篇 |
皮肤病学 | 17篇 |
神经病学 | 70篇 |
特种医学 | 22篇 |
外科学 | 230篇 |
综合类 | 3篇 |
预防医学 | 31篇 |
眼科学 | 10篇 |
药学 | 78篇 |
中国医学 | 13篇 |
肿瘤学 | 186篇 |
出版年
2023年 | 7篇 |
2021年 | 16篇 |
2020年 | 19篇 |
2019年 | 11篇 |
2018年 | 19篇 |
2017年 | 14篇 |
2016年 | 21篇 |
2015年 | 19篇 |
2014年 | 38篇 |
2013年 | 35篇 |
2012年 | 71篇 |
2011年 | 86篇 |
2010年 | 55篇 |
2009年 | 43篇 |
2008年 | 95篇 |
2007年 | 101篇 |
2006年 | 86篇 |
2005年 | 92篇 |
2004年 | 93篇 |
2003年 | 122篇 |
2002年 | 113篇 |
2001年 | 31篇 |
2000年 | 33篇 |
1999年 | 24篇 |
1998年 | 14篇 |
1997年 | 17篇 |
1996年 | 15篇 |
1995年 | 15篇 |
1994年 | 14篇 |
1993年 | 14篇 |
1992年 | 22篇 |
1991年 | 23篇 |
1990年 | 15篇 |
1989年 | 8篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 18篇 |
1985年 | 15篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1968年 | 3篇 |
1967年 | 2篇 |
排序方式: 共有1539条查询结果,搜索用时 125 毫秒
1.
2.
3.
4.
Kasahara M Ichinohe T Sano T Fukuda K Kaneko Y 《The Bulletin of Tokyo Dental College》2011,52(1):47-51
Varicella-zoster virus reactivation causes zoster (shingles), a syndrome characterized by severe pain and a vesicular rash. The present report details a case of varicella-zoster virus reactivation of the maxillary and mandibular division of the right trigeminal nerve without evidence of vesicular rash (zoster sine herpete). It is difficult to identify owing to no typical clinical signs such as vesicular eruption. Zoster sine herpete of the trigeminal nerve, in particular, is rarely reported. In this case, the diagnosis was based on clinical findings and was supported by the demonstration of an immunoglobulin G antibody. Zoster sine herpete of the trigeminal nerve, in particular, should be considered in patients with severe facial pain over specific dermatomes, if they do not demonstrate appreciable findings of traumatic neuropathy, tumor or herpes zoster. 相似文献
5.
OBJECTIVES: The aims of this study were to develop a new technique for determination of iron content of serum ferritin (ICF, micromol Fe/mg protein) and to investigate relations between ICF and clinical status in patients with hyperferritinemia. METHODS: ICF values were determined by a combination of immunoprecipitation of ferritin and direct colorimetric iron assay. One hundred fifty patients with hyperferritinemia were screened. Factor analysis of the results of 11 laboratory tests was applied to extract factors representing the clinical status of patients. Relations between the extracted factors and the ICF values or serum ferritin concentrations were assessed. RESULTS: Within-run coefficients of variation (CVs) of the ICF assay were <==5.7%. The mean ICF value of 150 patients was 0.423 micromol/mg (SD, 0.211 micromol/mg). Three factors representing clinical status were identified: inflammation, tissue cell damage, and body iron status. Serum ferritin level correlated with all three factors. In contrast, ICF correlated significantly only with the factor representing tissue cell damage (r = 0.293, p = 0.001), and this correlation was independent of inflammation and iron status (p = 0.008). CONCLUSIONS: ICF changes in response to tissue cell damage independent of inflammatory and body iron statuses, whereas serum ferritin changes in response to all three pathologic statuses. 相似文献
6.
7.
8.
9.
10.
The role of CD5 expression in thymic carcinoma: possible mechanism for interaction with CD5+ lymphoid stroma (microenvironment) 下载免费PDF全文
Naoki Hosaka Chisato Ohe Chika Miyasaka Yorika Nakano Noriko Sakaida Yoshiko Uemura Yukihito Saito Susumu Ikehara Airo Tsubura Hakuo Takahashi 《Histopathology》2016,68(3):450-455
Recently, an increasing number of TFE3 rearrangement‐associated tumours have been reported, such as TFE3 rearrangement‐associated perivascular epithelioid cell tumours (PEComas), melanotic Xp11 translocation renal cancers and melanotic Xp11 neoplasms. We have suggested that these tumours belong to a single clinicopathological spectrum. ‘Xp11 neoplasm with melanocytic differentiation’ or ‘melanotic Xp11 neoplasm’ have been proposed to designate this unique neoplasm. Herein, we describe the first case of an Xp11 neoplasm with melanocytic differentiation to be described in the prostate, bearing the novel NONO–TFE3 gene fusion. This study both adds to the spectrum regarding melanotic Xp11 neoplasms and expands its gene fusion spectrum. Moreover, we discuss the relationship of these rare tumours to neoplasms such as conventional PEComas, alveolar soft part sarcomas, malignant melanomas, clear cell sarcomas and Xp11 translocation renal cancers. 相似文献